Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Integrated Diagnostics Holdings ( (GB:IDHC) ) just unveiled an announcement.
Integrated Diagnostics Holdings (IDH) has expanded its Egyptian radiology portfolio by acquiring CAIRO RAY for Radiotherapy, a facility in East Cairo, for EGP 400 million. This acquisition is part of IDH’s strategy to enhance its radiology offerings alongside its leading pathology business. The move allows IDH to enter the radiotherapy sector, capitalizing on its growth potential driven by Egypt’s aging population and rising cancer prevalence. The acquisition strengthens Al Borg Scan’s network, positioning it as a top-tier provider in Egypt’s radiology and radiotherapy market. The newly acquired facility is expected to contribute positively to IDH’s results starting in 2026, as the company continues to expand its footprint and capture additional market share.
More about Integrated Diagnostics Holdings
Integrated Diagnostics Holdings (IDH) is a prominent diagnostics services provider in the Middle East and Africa, offering a comprehensive range of clinical pathology and radiology tests across Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. With over 40 years of experience, IDH has built a reputation for quality and safety, supported by internationally recognized accreditations. The company operates through core brands such as Al Borg, Al Borg Scan, and Al Mokhtabar, and has a scalable business model that supports both organic growth and strategic acquisitions in appealing markets.
Average Trading Volume: 366,265
Technical Sentiment Signal: Strong Sell
Current Market Cap: $209.3M
See more data about IDHC stock on TipRanks’ Stock Analysis page.